The value of E-cadherin/β-catenin expression in imprints of NCSLC: Relationship with clinicopathological factors

Diagnostic Cytopathology

Volumn 38, Issue 6, 2010, Pages 419-424

  Pagaki, Eumorfia ^a   Patsouris, Efstratios ^b   Gonidi, Maria ^b   Athanassiadou, Anna Maria ^b   Maurikakis, Myron ^b   Athanassiades, Peter ^b   Chelidonis, George ^b   Athanassiadou, Pauline ^b  

^a General Airforce Hospital   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cadherins; Catenins; Immunocytochemistry; Imprint smears; NSCLC

Indexed keywords

BETA CATENIN; UVOMORULIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

AGED; BETA CATENIN; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77952836170     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21188     Document Type: Article

References (47)

1. Pignatelli M, Vessey CJ. Adhesion molecules: Novel molecular tools in tumor pathology. Hum Pathol 1994;25:849-856. (Pubitemid 24292399)
2. Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RC, Fraumeni JF, Jr. Recent cancer trends in the United States. J Natl Cancer Inst 1995;87:175-182.
3. Mountain CF. Revisions in the international staging system for lung cancer. Chest 1997;111:1711-1717.
4. Hirsh FR, Franklin WA, Gazdar A, Bunn PA, Jr. Early detection in lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 2001;7:5-22.
5. Menger MD, Vollmar B. Adhesion molecules as determinants of disease: From molecular biology to surgical research. Br J Surg 1996;83:588-601. (Pubitemid 26163543)
6. Matsuura K, Kawanishi J, Fugiii S, et al. Altered expression of E-cadherin in gastric cancer tissues and carcinomatuos fluid. Br J Cancer 1992;66:1122-1130. (Pubitemid 23006154)
7. Hiscox S, Jiang WG. Expression of E-cadherin, alpha, beta and gamma catenin in human colorectal cancer. Anticancer Res 1997; 17:1349-1354.
8. Ihara A, Koizumi H, Hashizume R, Uchikoshi T. Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology 1996;23:1441-1447. (Pubitemid 26181227)
9. Cheng L, Nagabhushan M, Pretlow TP, Amini SB, Pretlow TG. Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol 1996;48:1375-1380. (Pubitemid 26135881)
10. Liu D, Huang C, Kameyama K, et al. E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer. Ann Thorac Surg 2001;71:949-955.
11. Kase S, Sugio K, Yamazaki K, Okamoto T, Yano T, Sugimachi K. Expession of E-cadherin and β-catenin in human non-small cell lung cancer and clinical significance. Clin Cancer Res 2000;6: 4789-4796. (Pubitemid 32110421)
12. Pantel K, Passlick B, Vogt J, et al. Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small cell lung cancer. J Clin Oncol 1998;16:1407-1413. (Pubitemid 28175758)
13. Bantis A, Gianopoulos A, Gonidi M, et al. Expression of p120, Ki-67 and PCNA as proliferation biomarkers in imprint smears of prostate carcinoma and their prognostic value. Cytopathology 2004; 15:25-31.
14. Greene DR, Taylor SR, Wheeler TM, Scardino PT. DNA ploidy by image analysis of individuals foci of prostate cancer: A preliminary report. Cancer Res 1991;51:4084-4089.
15. Koss LG, Melamed MR, Koss LG, Melamed MR, editors. Recognizing and classifying cells. Koss/diagnostic cytology. 5th ed. Philadelrhia: Lippincot Williams and Wilkins; 2006. p 119-120.
16. Werner M, Chott A, Fabiano A, Battifora H. Effect of formalin fixation and processing on immunohistochemistry. Am J Surg 2000; 24:1016-1019. (Pubitemid 30430490)
17. Creager AJ, Geisinger KR, Perrier ND, et al. Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast. Ann Surg 2004;239:61-66. (Pubitemid 38176373)
18. Aihara T, Munakata S, Morino H, Takatsuka Y. Touch imprint cytology and immunohistochemistry for assessment of sentinel lymph nodes in patients with breast cancer. Eur J Surg Oncol 2003;29:845-848. (Pubitemid 37493281)
19. Aihara T, Munakata S, Morino H, Takatsuka Y. Comparison of frozen sections and touch imprint cytology for evaluation of sentinel lymph node metastasis in breast cancer. Ann Surg Oncol 2004;11: 747-750. (Pubitemid 40486688)
20. Flens MJ, Van Der Valk P, Tadema TM, et al. The contribution of immunocytochemistry in diagnostic cytology. Comparisons and evaluation with immunohistology. Cancer 1990;65:2704-2711.
21. Hidaka N, Nagao T, Asoh A, Kondo Y, Nagao K. Expression Ecadherin, a-catenin, β-catenin, g-catenin in bronchioalveolar carcinoma and conventional pulmonary adenocarcinoma: An immunocytochemical study. Mod Pathol 1998;11:1039-1045.
22. De-Leeuw WJF, Berx G, Vos CBJ, et al. Simultaneous loss of Ecadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997;183:404-411. (Pubitemid 27509246)
23. Nuruki K, Toyoyama H, Ueno S, et al. E-cadherin but not N-cadherin expression is correlated with intracellular distribution of catenins in human hepatocellular carcinomas. Oncol Rep 1998;5:1109-1114. (Pubitemid 28372570)
24. Xiangming C, Hokita S, Nuruki K, et al. The expression of cadherin- catenin complex in association with the clinicopathological features of early gastric cancer. Surg Today 1998;28:587-594. (Pubitemid 28287700)
25. Wijnhoven BPL, Dinjens WNM, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 2000;87: 992-1005. (Pubitemid 30496847)
26. Shiozaki H, Oka H, Inone M, Tamura S, Mondon M. E-cadherin mediated systen in cancer cells. Cancer suppl 1996;77:1605-1613. (Pubitemid 26111841)
27. Bohm M, Totzeck B, Wieland I. Differences of E-cadherin expression levels and patterns in human lung cancer. Ann Hematol 1994; 68:81-83. (Pubitemid 24083890)
28. Nagafuchi A, Shirayoshi Y, Okazaki Y, Yasuda K, Takeichi M. Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA. Nature 1987;329:341-343. (Pubitemid 17125410)
29. Mcneil H, Ozawa M, Kemler R, Nelson WJ. Novel function of the cell adhesion molecule uvomorulin as an inducer of cell surface polarity. Cell 1990;62:309-316. (Pubitemid 20233537)
30. Oka H, Shiozaki H, Kobayashi K, et al. Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch A Pathol Anat Histopathol 1992;421:149-156.
31. Oka H, Shiozaki H, Kobayashi K, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993;53:1696-1701. (Pubitemid 23113254)
32. Shimoyama Y, Hirohashi S, Hirano S, et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res 1989;49:2128-2133. (Pubitemid 19106526)
33. Bongiorno PF, Al-Kasspooles M, Lee SW, et al. E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. Br J Cancer 1995;71:166-172.
34. Shibanuma H, Hirano T, Tsuji K, et al. Influence of E-cadherin dysfunction upon local invasion and metastasis in nonsmall cell lung cancer. Lung Cancer 1998;22:85-95. (Pubitemid 29050850)
35. Sulzer MA, Leers MPG, Van Noord JA, Bollen ECM. Theunissen PHMH: Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer. Am J Respir Crit Care Med 1998;157: 1319-1323. (Pubitemid 28225205)
36. Lim SC, Jang IG, Kim YC. The role of E-cadherin expression in non-small cell lung cancer. J Korean Med Sci 2000;15:501-506.
37. Smythe WR, Williams JP, Wheelock MJ, et al. Cadherin and catenin expression in normal brochial epithelium and non-small cell lung cancer. Lung Cancer 1999;24:157-168.
38. Nawrocki B, Polette M, Van Hengel J, Tournier JM, Van Roy F, Birembaut P. Cytoplasmic redistribution of E-cadherin - Catenin adhesion complex is associated with down - Regulated tyrosine prosphorylation of E-cadherin in human bronchopulmonary carcinomas. Am J Pathol 1998;153:1521-1530. (Pubitemid 28509909)
39. Herbst RS, Yano S, Kuniyasu H, et al. Differential expression of Ecadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res 2000;6: 790-797. (Pubitemid 30159331)
40. Bremnes RM, Veve R, Hirch FR, Franklin WA. The E-Cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 2002;36:115-124. (Pubitemid 34302891)
41. Hashimoto M, Niwa O, Nitta Y, Takeichi M, Yokoro K. Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn J Cancer Res 1989;80:459-463. (Pubitemid 20038136)
42. Miyata M, Shiozaki H, Ihara K, Shimaya K, Oka H, Kabowaki T. Relationship between E-cadherin expression and lymph node metastasis in human esophageal cancer. Int J Oncol 1994;4:61-65. (Pubitemid 24012560)
43. Kabowaki T, Shiozaki H, Inoue M, et al. E-cadherin and a-catenin expression in human esophageal cancer. Cancer Res 1994;54:291-296. (Pubitemid 2019279)
44. Becker KF, Atnikson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54:3845-3852. (Pubitemid 24241205)
45. Matsui S, Shiozaki H, Inoue M, et al. Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer. Virchows Arch A Pathol Anat Histopathol 1994;424:375-381. (Pubitemid 24185390)
46. Prinen RT, Hirvikoski P, Johansson RT, Hollmén S, Kosma V-M. Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J Clin Pathol 2001;54:391-395. (Pubitemid 32458139)
47. Brown MS, Ye J, Rawson RB, Goldstein JL. Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans. Cell 2000;100:391-398.